These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2036490)

  • 1. Factors controlling immunoglobulin production and B cell proliferation.
    Fridman WH
    Bull Cancer; 1991; 78(2):195-201. PubMed ID: 2036490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomeric IgG2 enhances Ig production and proliferation in human B cells.
    Kimata H; Yoshida A; Ishioka C; Jiang Y; Kusunoki T; Mikawa H
    Biotechnol Ther; 1993; 4(1-2):1-16. PubMed ID: 8374507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of hybridoma B-cell proliferation by immunoglobulin-binding factor.
    Teillaud JL; Mathiot C; Amigorena S; Brunati S; Moncuit J; Fridman WH
    Cancer Detect Prev; 1988; 12(1-6):115-23. PubMed ID: 3263193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B lymphocyte regulation of the immune system. II. Inhibition of Fc receptor expression of lymphocytes by BEF, a lymphokine of B cell origin.
    del Guercio P; Zanetti M; del Guercio MF; Katz DH
    J Immunol; 1985 Jun; 134(6):3926-33. PubMed ID: 3157754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective isotype-specific regulation of IgA anti-erythrocyte autoantibody-forming cells in NZB mice.
    Moore JS; Hoover RG
    J Immunol; 1989 Jun; 142(12):4282-8. PubMed ID: 2786026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory mechanism of the proliferative responses of resting B cells: feedback regulation by a lymphokine (suppressive B-cell factor) produced by Fc receptor-stimulated B cells.
    Ohno T; Miyama-Inaba M; Masuda T; Fukuma K; Ajisaka K; Suzuki R; Kumagai K; Kanoh T; Uchino H
    Immunology; 1987 May; 61(1):35-41. PubMed ID: 2953673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cytokines in human B lymphocyte growth and differentiation.
    Banchereau J; Blanchard D; Brière F; Galizzi JP; Garrone P; Hermann P; Lebecque S; Rousset F
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):61-6. PubMed ID: 7685519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FcR epsilon+ lymphocytes and regulation of the IgE antibody system. I. A new class of molecules, termed IgE-induced regulants (EIR), which modulate FcR epsilon expression by lymphocytes.
    Marcelletti JF; Katz DH
    J Immunol; 1984 Dec; 133(6):2821-8. PubMed ID: 6238084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific human immunoglobulin production in SCID mice transplanted with human peripheral lymphocytes is dependent on CD4+ CD45RO+ T cells.
    Mårtensson C; Kristensson K; Kalliomäki S; Borrebaeck CA; Carlsson R
    Immunology; 1994 Oct; 83(2):171-9. PubMed ID: 7835932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc receptors, immunoglobulin-binding factors and B chronic lymphocytic leukemia.
    Fridman WH; Mathiot C; Montcuit J; Teillaud JL
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):311-5. PubMed ID: 3065731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lymphokine derived from human IgG Fc receptor-bearing B cells: its suppressive effect on activated T and B lymphocytes including tumour cells in vitro.
    Suzuki T; Park YH; Miyama-Inaba M; Masuda T; Saji H; Nagata I; Uchino H
    Immunology; 1985 Jul; 55(3):427-36. PubMed ID: 3160654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FcR epsilon+ lymphocytes and regulation of the IgE antibody system. IV. Delineation of target cells and mechanisms of action of SFA and EFA in inhibiting in vitro induction of FcR epsilon expression.
    Marcelletti JF; Katz DH
    J Immunol; 1984 Dec; 133(6):2845-51. PubMed ID: 6238087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular control of B lymphocyte growth and differentiation.
    Banchereau J; Brière F; Liu YJ; Rousset F
    Stem Cells; 1994 May; 12(3):278-88. PubMed ID: 7521239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FcR epsilon+ lymphocytes and regulation of the IgE antibody system. II. FcR epsilon+ B lymphocytes initiate a cascade of cellular and molecular interactions that control FcR epsilon expression and IgE production.
    Marcelletti JF; Katz DH
    J Immunol; 1984 Dec; 133(6):2829-36. PubMed ID: 6238085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
    Croft M; Swain SL
    J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.
    Yoshizaki K; Nakagawa T; Kaieda T; Muraguchi A; Yamamura Y; Kishimoto T
    J Immunol; 1982 Mar; 128(3):1296-301. PubMed ID: 6799573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of helper/inducer T lymphocytes. IV. Stimulation of resting and activated B cells by Th1 and Th2 clones.
    Abbas AK; Urioste S; Collins TL; Boom WH
    J Immunol; 1990 Mar; 144(6):2031-7. PubMed ID: 2138191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells.
    Montes CL; Acosta-Rodríguez EV; Mucci J; Zuniga EI; Campetella O; Gruppi A
    Eur J Immunol; 2006 Jun; 36(6):1474-85. PubMed ID: 16688679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD57+ T cells derived from peripheral blood do not support immunoglobulin production by B cells.
    Andersson E; Ohlin M; Borrebaeck CA; Carlsson R
    Cell Immunol; 1995 Jul; 163(2):245-53. PubMed ID: 7541727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal requirements for growth and differentiation of activated murine B lymphocytes.
    Müller W; Kühn R; Goldmann W; Tesch H; Smith FI; Radbruch A; Rajewsky K
    J Immunol; 1985 Aug; 135(2):1213-9. PubMed ID: 3874233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.